Indication for administration of AS V (Antisnake venom) in Viper bite?
Correct Answer: All of the above
Description: Ans. d (All of the above) (Ref: Pilley Textbook of Toxicolgy 7th edition, p. 450; Harrison's 17th ed., p. 2742)Use of Acetylcholinesterase Inhibitors in Neurotoxic Snake Envenomation1. Patients with clear, objective evidence of neurotoxicity after snakebite (e.g., ptosis or inability to maintain upward gaze) should receive a trial of edrophonium (if available) or neostigmine.a. Pretreat with atropine: 0.6 mg IV (children, 0.02 mg/kg; minimum of 0.1 mg)b. Follow with:Edrophonium: 10 mg IV (children, 0.25 mg/kg) orNeostigmine: 1.5-2.0 mg IM (children, 0.025-0.08 mg/kg)2. If objective improvement is evident at 5 min, continue neostigmine at a dose of 0.5 mg (children, 0.01 mg/kg) every 30 min as needed, with continued administration of atropine by continuous infusion of 0.6 mg over 8 h (children, 0.02 mg/ kg over 8 h).3. Maintain vigilance regarding aspiration risk, and secure the airway with endotracheal intubation as needed.REID'S CRITERIA FOR ADMINISTRATION OF ASV# Leukocytosis > 13,000-15,000/cu mm# Thrombocytopenia < 80,000/cu mm# Renal failure# DIC# Soft tissue swelling involving or crossing joint nearby site of bite# Systemic symptoms/signs of neuroparalytic bite (vomiting, abdominal pain, giddiness, ptosis, etc).Dose of ASVLimb Area InvolvementDose< 1/3 of Limb area50 ml1/3-1/2 Limb area100 ml>50% of Limb area150-200 mlASV should be given within 2 days preferably can be given upto 5-7 days.Comparison of Antivenoms Recently Available for Treatment of Pit Viper Bites in the U Antivenin (Crotalidae) PolyvalentCroFabAvailable since19542000OriginEquineOvineSnakes used in manufactureCrotalus adamanteusC. adamanteus C. atroxC. atrox C. durissus terrificusC. scutulatus Bothrops atroxAgkistrodon piscivorusContainsSkin testing recommended byIgG, equine albuminFab fragmentsmanufacturerYesNoPretreatment with antihistaminesYesNoDry bite-doseNoneNoneMild - dose0 or 5 vials4 vialsModerate - dose10 vials4-6 vialsSevere - dose15-20 vials6 vialsRepeat dosingAs neededRepeat starting dose if patient fails to stabilize.After stabilization, give 2 vials q6h for 3 more doses. (Alternatively, re-dose on an as needed basis with close observation for recurrence of abnormalities.)Volume of diluent1000 mL250 mLAdminister over2 h1 hIncidence of anaphyiacticoid reacn23-56%14%incidence of delayed serum sickness18-86%3%
Category:
Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now